151 related articles for article (PubMed ID: 1684649)
1. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism.
Brougham LR; Conway PG; Ellis DB
Neuropharmacology; 1991 Oct; 30(10):1137-40. PubMed ID: 1684649
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
Rivest R; Marsden CA
Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
[TBL] [Abstract][Full Text] [Related]
3. Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons.
Gudelsky GA; Nwajei EE; Defife K; Nash JF
Synapse; 1992 Dec; 12(4):304-11. PubMed ID: 1361248
[TBL] [Abstract][Full Text] [Related]
4. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
[TBL] [Abstract][Full Text] [Related]
5. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
Szczepanik AM; Wilmot CA
Neurosci Lett; 1997 Aug; 231(2):91-4. PubMed ID: 9291148
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
Gray AM; Connick JH
Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
[TBL] [Abstract][Full Text] [Related]
7. Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study.
Rivest R; Jolicoeur FB; Marsden CA
Brain Res; 1991 Mar; 544(1):86-93. PubMed ID: 1677303
[TBL] [Abstract][Full Text] [Related]
8. Effects of amfonelic acid and GBR 12909 on the haloperidol- and clozapine-induced activation of dopamine neurons.
Gudelsky GA; Nwajei EE; Defife K; Nash JF
Psychopharmacol Bull; 1992; 28(3):275-9. PubMed ID: 1480731
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical effects of chronic co-administration of ritanserin and haloperidol: comparison with clozapine effects.
Lappalainen J; Hietala J; Koulu M; Syvälahti E
Eur J Pharmacol; 1990 Nov; 190(3):403-7. PubMed ID: 2125564
[TBL] [Abstract][Full Text] [Related]
10. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
Kitaichi K; Yamada K; Hasegawa T; Furukawa H; Nabeshima T
Jpn J Pharmacol; 1994 Oct; 66(2):181-9. PubMed ID: 7532732
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
Lappalainen J; Hietala J; Koulu M; Sjöholm B; Syvälahti E
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):861-72. PubMed ID: 1722342
[TBL] [Abstract][Full Text] [Related]
12. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
Zetterström T; Sharp T; Ungerstedt U
Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
Rivest R; Marsden CA
Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
[TBL] [Abstract][Full Text] [Related]
15. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K
Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
Commissiong JW; Slimovitch C; Toffano G
Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
[TBL] [Abstract][Full Text] [Related]
17. [Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats].
Bogdanov MB; Gaĭnetdinov RR; Kudrin VS; Medvedev OS; Val'dman AV
Biull Eksp Biol Med; 1991 May; 111(5):505-7. PubMed ID: 1715214
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
Nicolaou NM
Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
[TBL] [Abstract][Full Text] [Related]
19. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
Karoum F; Egan MF
Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
[TBL] [Abstract][Full Text] [Related]
20. Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.
Miller HH; Shore PA
Eur J Pharmacol; 1982 Feb; 78(1):33-44. PubMed ID: 6122585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
